Log in
NASDAQ:FPRX

Five Prime Therapeutics SEC Filings & 10K Form

$4.49
+0.29 (+6.90 %)
(As of 09/25/2020 12:00 AM ET)
Add
Compare
Today's Range
$4.18
Now: $4.49
$4.62
50-Day Range
$3.81
MA: $4.43
$6.12
52-Week Range
$1.75
Now: $4.49
$7.34
Volume347,774 shs
Average Volume398,616 shs
Market Capitalization$164.46 million
P/E RatioN/A
Dividend YieldN/A
Beta2.68

SEC Filings

Five Prime Therapeutics (NASDAQ:FPRX) SEC Filings

DateFilerForm TypeView
09/24/2020
6:49 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF GP HOLDINGS LLC (Reporting)
BVF I GP LLC (Reporting)
BVF II GP LLC (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Five Prime Therapeutics (Issuer)
LAMPERT MARK N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2020
5:07 AM
Five Prime Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/24/2020
12:46 PM
Collins Helen Louise (Reporting)
Five Prime Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2020
11:17 AM
Five Prime Therapeutics (Filer)
Form CT ORDER
05/20/2020
3:14 PM
Five Prime Therapeutics (Issuer)
RINGO WILLIAM R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2020
7:02 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF GP HOLDINGS LLC (Reporting)
BVF I GP LLC (Reporting)
BVF II GP LLC (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Five Prime Therapeutics (Issuer)
LAMPERT MARK N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2020
6:51 PM
BVF GP HOLDINGS LLC (Reporting)
BVF I GP LLC (Reporting)
BVF II GP LLC (Reporting)
Five Prime Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/18/2020
9:36 AM
Five Prime Therapeutics (Issuer)
Jensen Peder (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2020
4:49 PM
Five Prime Therapeutics (Issuer)
Nicholson Garry A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2020
4:46 PM
Dhingra Kapil (Reporting)
Five Prime Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2020
4:43 PM
BERGER FRANKLIN M (Reporting)
Five Prime Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2020
4:33 PM
Five Prime Therapeutics (Issuer)
SCHAFER CAROL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2020
4:30 PM
Five Prime Therapeutics (Issuer)
Lyons-Williams Lori (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2020
3:10 PM
Five Prime Therapeutics (Filer)
Form DEFA14A
04/20/2020
6:55 PM
Five Prime Therapeutics (Issuer)
RINGO WILLIAM R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/14/2020
3:38 PM
Civik Thomas (Reporting)
Five Prime Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/14/2020
8:06 AM
Five Prime Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/06/2020
3:06 PM
Five Prime Therapeutics (Filer)
Form 8-K/A
04/03/2020
5:04 AM
Five Prime Therapeutics (Filer)
Form DEF 14A
03/23/2020
11:11 AM
Collins Helen Louise (Reporting)
Five Prime Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2020
2:26 PM
Five Prime Therapeutics (Issuer)
RINGO WILLIAM R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2020
5:32 PM
Five Prime Therapeutics (Issuer)
Smith David V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2020
7:35 AM
Five Prime Therapeutics (Issuer)
White David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2020
3:11 PM
Five Prime Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2020
7:29 PM
Five Prime Therapeutics (Issuer)
Sarena Francis Willard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2020
7:22 PM
Collins Helen Louise (Reporting)
Five Prime Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2020
7:13 PM
Five Prime Therapeutics (Issuer)
White David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2020
7:26 PM
Five Prime Therapeutics (Issuer)
RINGO WILLIAM R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2020
8:28 AM
Five Prime Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2020
3:20 PM
Five Prime Therapeutics (Subject)
GREAT POINT PARTNERS LLC (Filed by)
Form SC 13G/A
02/06/2020
5:51 PM
Collins Helen Louise (Reporting)
Five Prime Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2020
5:49 PM
Five Prime Therapeutics (Issuer)
Sarena Francis Willard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/21/2020
3:10 PM
Five Prime Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/21/2020
12:34 PM
Five Prime Therapeutics (Issuer)
RINGO WILLIAM R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/21/2020
12:33 PM
Five Prime Therapeutics (Issuer)
RINGO WILLIAM R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2020
5:16 AM
Five Prime Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/26/2019
4:59 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Five Prime Therapeutics (Issuer)
LAMPERT MARK N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2019
3:31 PM
Five Prime Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2019
5:39 PM
Five Prime Therapeutics (Issuer)
RINGO WILLIAM R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2019
5:13 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Five Prime Therapeutics (Issuer)
LAMPERT MARK N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2019
8:49 AM
Five Prime Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
12/04/2019
5:28 PM
BERGER FRANKLIN M (Reporting)
Five Prime Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2019
4:59 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Five Prime Therapeutics (Issuer)
LAMPERT MARK N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2019
3:07 PM
Five Prime Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/20/2019
11:44 AM
Five Prime Therapeutics (Issuer)
RINGO WILLIAM R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2019
11:11 AM
Five Prime Therapeutics (Subject)
FMR LLC (Filed by)
Form SC 13G/A
11/08/2019
4:17 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Five Prime Therapeutics (Subject)
Form SC 13G/A
11/07/2019
6:22 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Five Prime Therapeutics (Issuer)
LAMPERT MARK N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2019
4:16 PM
Five Prime Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2019
3:11 PM
Five Prime Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2019
5:24 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Five Prime Therapeutics (Issuer)
LAMPERT MARK N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/25/2019
4:43 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Five Prime Therapeutics (Issuer)
LAMPERT MARK N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/21/2019
4:30 PM
Five Prime Therapeutics (Issuer)
RINGO WILLIAM R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2019
3:12 PM
Five Prime Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/09/2019
3:06 PM
Five Prime Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/08/2019
6:30 PM
Five Prime Therapeutics (Issuer)
RINGO WILLIAM R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/08/2019
4:40 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Five Prime Therapeutics (Issuer)
LAMPERT MARK N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2019
3:42 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Five Prime Therapeutics (Issuer)
LAMPERT MARK N (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/02/2019
3:42 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Five Prime Therapeutics (Subject)
Form SC 13G/A
09/19/2019
3:32 PM
Five Prime Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/04/2019
12:20 PM
Five Prime Therapeutics (Issuer)
Williams Lewis T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2019
12:18 PM
Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2019
12:15 PM
Five Prime Therapeutics (Issuer)
Sarena Francis Willard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2019
12:12 PM
Collins Helen Louise (Reporting)
Five Prime Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2019
11:15 PM
Five Prime Therapeutics (Filer)
Form EFFECT
08/22/2019
5:50 PM
Collins Helen Louise (Reporting)
Five Prime Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2019
3:07 PM
Five Prime Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2019
3:47 PM
Five Prime Therapeutics (Filer)
Form S-3/A
08/07/2019
7:48 PM
Five Prime Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2019
3:17 PM
Five Prime Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/02/2019
9:17 AM
Five Prime Therapeutics (Filer)
Form CT ORDER
08/02/2019
9:11 AM
Five Prime Therapeutics (Filer)
Form CT ORDER
08/02/2019
9:00 AM
Five Prime Therapeutics (Filer)
Form CT ORDER
07/31/2019
3:10 PM
Five Prime Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/31/2019
3:08 PM
Five Prime Therapeutics (Subject)
Form SC TO-I/A
07/10/2019
1:58 PM
Five Prime Therapeutics (Subject)
FMR LLC (Filed by)
Form SC 13G/A
07/01/2019
5:08 AM
Five Prime Therapeutics (Subject)
Form SC TO-I
06/28/2019
3:07 PM
Five Prime Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2019
3:35 PM
Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2019
3:30 PM
Five Prime Therapeutics (Issuer)
Sarena Francis Willard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2019
3:28 PM
Collins Helen Louise (Reporting)
Five Prime Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2019
3:25 PM
Five Prime Therapeutics (Issuer)
Smith David V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2019
3:10 PM
Five Prime Therapeutics (Issuer)
Lyons-Williams Lori (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2019
3:08 PM
Five Prime Therapeutics (Issuer)
Lyons-Williams Lori (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/24/2019
3:11 PM
Five Prime Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2019
5:37 PM
Five Prime Therapeutics (Issuer)
Nicholson Garry A (Reporting)
Form 3/A
06/12/2019
5:28 PM
Five Prime Therapeutics (Issuer)
Williams Lewis T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2019
5:26 PM
Five Prime Therapeutics (Issuer)
SCHAFER CAROL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2019
5:23 PM
Five Prime Therapeutics (Issuer)
RINGO WILLIAM R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2019
5:21 PM
BERGER FRANKLIN M (Reporting)
Five Prime Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2019
5:18 PM
Five Prime Therapeutics (Issuer)
Nicholson Garry A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2019
5:15 PM
Five Prime Therapeutics (Issuer)
Jensen Peder (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2019
5:11 PM
Dhingra Kapil (Reporting)
Five Prime Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2019
3:09 PM
Five Prime Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2019
12:53 PM
Five Prime Therapeutics (Issuer)
Knickerbocker Aron Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2019
5:42 PM
Five Prime Therapeutics (Issuer)
SCHAFER CAROL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2019
5:34 PM
Five Prime Therapeutics (Issuer)
SCHAFER CAROL (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/16/2019
5:29 PM
Five Prime Therapeutics (Issuer)
Irving Bryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2019
3:11 PM
Five Prime Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2019
4:11 PM
Five Prime Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
This page was last updated on 9/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.